Skip to main content
Erschienen in: Lung 4/2013

01.08.2013

Why Do Nonsurvivors from Community-Acquired Pneumonia Not Receive Ventilatory Support?

verfasst von: Torsten T. Bauer, Tobias Welte, Richard Strauss, Helge Bischoff, Klaus Richter, Santiago Ewig

Erschienen in: Lung | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

We investigated rates and predictors of ventilatory support during hospitalization in seemingly not severely compromised nonsurvivors of community-acquired pneumonia (CAP).

Methods

We used the database from the German nationwide mandatory quality assurance program including all hospitalized patients with CAP from 2007 to 2011. We selected a population not residing in nursing homes, not bedridden, and not referred from another hospital. Predictors of ventilatory support were identified using a multivariate analysis.

Results

Overall, 563,901 patients (62.3 % of the whole population) were included. Mean age was 69.4 ± 16.6 years; 329,107 (58.4 %) were male. Mortality was 39,895 (7.1 %). A total of 28,410 (5.0 %) received ventilatory support during the hospital course, and 76.3 % of nonsurvivors did not receive ventilatory support (62.6 % of those aged <65 years and 78 % of those aged ≥65 years). Higher age (relative risk (RR) 0.48, 95 % confidence interval (CI) 0.44–0.51), failure to assess gas exchange (RR 0.18, 95 % CI 0.14–0.25) and to administer antibiotics within 8 h of hospitalization (RR 0.48, 95 % CI 0.39–0.59) were predictors of not receiving ventilatory support during hospitalization. Death from CAP occurred significantly earlier in the nonventilated group (8.2 ± 8.9 vs. 13.1 ± 14.1 days; p < 0.0001).

Conclusions

The number of nonsurvivors without obvious reasons for withholding ventilatory support is disturbingly high, particularly in younger patients. Both performance predictors for not being ventilated remain ambiguous, because they may reflect either treatment restrictions or deficient clinical performance. Elucidating this ambiguity will be part of the forthcoming update of the quality assurance program.
Literatur
1.
Zurück zum Zitat Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury G, Wood V, Hill AT (2010) Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 65:878–883CrossRefPubMed Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury G, Wood V, Hill AT (2010) Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 65:878–883CrossRefPubMed
2.
Zurück zum Zitat Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382CrossRefPubMed Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382CrossRefPubMed
3.
Zurück zum Zitat Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G (2009) New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 64:1062–1069CrossRefPubMed Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G (2009) New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 64:1062–1069CrossRefPubMed
4.
Zurück zum Zitat McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN (2009) Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 169:1525–1531CrossRefPubMed McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN (2009) Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 169:1525–1531CrossRefPubMed
5.
Zurück zum Zitat Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menéndez R, Lopardo G, Torres A, Rossi P, Ramirez JA, Community-Acquired Pneumonia Organization (CAPO) Investigators (2009) Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: community-acquired pneumonia organization international cohort study results. Arch Intern Med 169:1515–1524CrossRefPubMed Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menéndez R, Lopardo G, Torres A, Rossi P, Ramirez JA, Community-Acquired Pneumonia Organization (CAPO) Investigators (2009) Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: community-acquired pneumonia organization international cohort study results. Arch Intern Med 169:1515–1524CrossRefPubMed
6.
Zurück zum Zitat Ewig S, Torres A (2011) Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality. Eur Respir J 38:253–602CrossRefPubMed Ewig S, Torres A (2011) Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality. Eur Respir J 38:253–602CrossRefPubMed
7.
Zurück zum Zitat Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, Anzueto A, Mortensen EM (2011) Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 38:878–887CrossRefPubMed Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, Anzueto A, Mortensen EM (2011) Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 38:878–887CrossRefPubMed
8.
Zurück zum Zitat Chalmers JD, Taylor JK, Mandal P, Choudhury G, Singanayagam A, Akram AR, Hill AT (2011) Validation of the infectious diseases society of America/American thoracic society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 53:503–511CrossRefPubMed Chalmers JD, Taylor JK, Mandal P, Choudhury G, Singanayagam A, Akram AR, Hill AT (2011) Validation of the infectious diseases society of America/American thoracic society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 53:503–511CrossRefPubMed
9.
Zurück zum Zitat van der Steen JT, Ooms ME, Adèr HJ, Ribbe MW, van der Wal G (2002) Withholding antibiotic treatment in pneumonia patients with dementia: a quantitative observational study. Arch Intern Med 162:1753–1760CrossRefPubMed van der Steen JT, Ooms ME, Adèr HJ, Ribbe MW, van der Wal G (2002) Withholding antibiotic treatment in pneumonia patients with dementia: a quantitative observational study. Arch Intern Med 162:1753–1760CrossRefPubMed
10.
Zurück zum Zitat Lee JS, Primack BA, Mor MK, Stone RA, Obrosky DS, Yealy DM, Fine MJ (2011) Processes of care and outcomes for community-acquired pneumonia. Am J Med 124(1175):e9–17PubMed Lee JS, Primack BA, Mor MK, Stone RA, Obrosky DS, Yealy DM, Fine MJ (2011) Processes of care and outcomes for community-acquired pneumonia. Am J Med 124(1175):e9–17PubMed
11.
Zurück zum Zitat Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, Weber GF, Petrillo MK, Houck PM, Fine JM (1997) Quality of care, process, and outcomes in elderly patients with pneumonia. J Am Med Assoc 278:2080–2084CrossRef Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, Weber GF, Petrillo MK, Houck PM, Fine JM (1997) Quality of care, process, and outcomes in elderly patients with pneumonia. J Am Med Assoc 278:2080–2084CrossRef
12.
Zurück zum Zitat Blot SI, Rodriguez A, Solé-Violán J, Blanquer J, Almirall J, Rello J, Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators (2007) Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia. Crit Care Med 35:2509–2514CrossRefPubMed Blot SI, Rodriguez A, Solé-Violán J, Blanquer J, Almirall J, Rello J, Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators (2007) Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia. Crit Care Med 35:2509–2514CrossRefPubMed
13.
Zurück zum Zitat Capelastegui A, España PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I, Bilbao A (2004) Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis 39:955–963CrossRefPubMed Capelastegui A, España PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I, Bilbao A (2004) Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis 39:955–963CrossRefPubMed
14.
Zurück zum Zitat Marrie TJ, Fine MJ, Kapoor WN, Coley CM, Singer DE, Obrosky DS (2002) Community-acquired pneumonia and do not resuscitate orders. J Am Geriatr Soc 50:290–299CrossRefPubMed Marrie TJ, Fine MJ, Kapoor WN, Coley CM, Singer DE, Obrosky DS (2002) Community-acquired pneumonia and do not resuscitate orders. J Am Geriatr Soc 50:290–299CrossRefPubMed
15.
Zurück zum Zitat Tabak YP, Johannes RS, Silber JH, Kurtz SG (2005) Should do-not-resuscitate status be included as a mortality risk adjustor? The impact of DNR variations on performance reporting. Med Care 43:658–666CrossRefPubMed Tabak YP, Johannes RS, Silber JH, Kurtz SG (2005) Should do-not-resuscitate status be included as a mortality risk adjustor? The impact of DNR variations on performance reporting. Med Care 43:658–666CrossRefPubMed
16.
Zurück zum Zitat Simpson JC, Macfarlane JT, Watson J, Woodhead MA (2000) A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British thoracic society research committee and public health laboratory service. Thorax 55:1040–1045CrossRefPubMed Simpson JC, Macfarlane JT, Watson J, Woodhead MA (2000) A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British thoracic society research committee and public health laboratory service. Thorax 55:1040–1045CrossRefPubMed
17.
Zurück zum Zitat Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ (2002) Causes of death for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 162:1059–1064CrossRefPubMed Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ (2002) Causes of death for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 162:1059–1064CrossRefPubMed
18.
Zurück zum Zitat Corrales-Medina VF, Suh KN, Rose G, Chirinos JA, Doucette S, Cameron DW, Fergusson DA (2011) Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 8:e1001048CrossRefPubMed Corrales-Medina VF, Suh KN, Rose G, Chirinos JA, Doucette S, Cameron DW, Fergusson DA (2011) Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 8:e1001048CrossRefPubMed
19.
Zurück zum Zitat Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ (2012) Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125:773–781CrossRefPubMed Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ (2012) Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125:773–781CrossRefPubMed
20.
Zurück zum Zitat Aliberti S, Amir A, Peyrani P, Mirsaeidi M, Allen M, Moffett BK, Myers J, Shaib F, Cirino M, Bordon J, Blasi F, Ramirez JA (2008) Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest 134:955–962CrossRefPubMed Aliberti S, Amir A, Peyrani P, Mirsaeidi M, Allen M, Moffett BK, Myers J, Shaib F, Cirino M, Bordon J, Blasi F, Ramirez JA (2008) Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest 134:955–962CrossRefPubMed
21.
Zurück zum Zitat Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J (2012) Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J 39:156–162CrossRefPubMed Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J (2012) Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J 39:156–162CrossRefPubMed
22.
Zurück zum Zitat Wunsch H, Angus DC, Harrison DA, Collange O, Fowler R, Hoste EA, de Keizer NF, Kersten A, Linde-Zwirble WT, Sandiumenge A, Rowan KM (2008) Variation in critical care services across North America and Western Europe. Crit Care Med 36:2787–2793CrossRefPubMed Wunsch H, Angus DC, Harrison DA, Collange O, Fowler R, Hoste EA, de Keizer NF, Kersten A, Linde-Zwirble WT, Sandiumenge A, Rowan KM (2008) Variation in critical care services across North America and Western Europe. Crit Care Med 36:2787–2793CrossRefPubMed
23.
Zurück zum Zitat Sinuff T, Kahnamoui K, Cook DJ, Luce JM, Levy MM, Values Ethics and Rationing in Critical Care Task Force (2004) Rationing critical care beds: a systematic review. Crit Care Med 32:1588–1597CrossRefPubMed Sinuff T, Kahnamoui K, Cook DJ, Luce JM, Levy MM, Values Ethics and Rationing in Critical Care Task Force (2004) Rationing critical care beds: a systematic review. Crit Care Med 32:1588–1597CrossRefPubMed
24.
Zurück zum Zitat Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71–79CrossRefPubMed Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71–79CrossRefPubMed
Metadaten
Titel
Why Do Nonsurvivors from Community-Acquired Pneumonia Not Receive Ventilatory Support?
verfasst von
Torsten T. Bauer
Tobias Welte
Richard Strauss
Helge Bischoff
Klaus Richter
Santiago Ewig
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Lung / Ausgabe 4/2013
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-013-9467-3

Weitere Artikel der Ausgabe 4/2013

Lung 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.